Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 971-976

  Zhou, Jiansuo ^a   Zhang, Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Acute cerebral infarction; microRNA 21; microRNA 24; N2A neuroblastoma cells; Oxygen glucose deprivation

Indexed keywords

BECLIN 1; BIM PROTEIN; BIOLOGICAL MARKER; CASPASE 3; MICRORNA 21; MICRORNA 24; PROTEIN BCL 2; X LINKED INHIBITOR OF APOPTOSIS; MICRORNA; MIRN21 MICRORNA, HUMAN; MIRN24 MICRORNA, HUMAN; PROTEIN BAX; XIAP PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROBLASTOMA CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REOXYGENATION; RISK FACTOR; STROKE PATIENT; UPREGULATION; WESTERN BLOTTING; ACUTE DISEASE; ANIMAL; BLOOD; BRAIN INFARCTION; CELL HYPOXIA; CHEMISTRY; DOWN REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ACUTE DISEASE; AGED; ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL HYPOXIA; CELL LINE, TUMOR; CEREBRAL INFARCTION; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICE; MICRORNAS; MIDDLE AGED; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84903278538     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2245     Document Type: Article

References (25)

1. Rink C and Khanna S: MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 43: 521-528, 2011.
2. Laterza OF, Lim L, Garrett-Engele PW, et al: Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977-1983, 2009.
3. Weng H, Shen C, Hirokawa G, et al: Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 32: 135-141, 2011.
4. Zeng L, Liu J, Wang Y, et al: MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 3: 1265-1272, 2011.
5. Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of MicroRNAs in young stroke patients. PLoS One 4: e7689, 2009.
6. Jeyaseelan K, Lim KY and Armugam A: MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39: 959-966, 2008. (Pubitemid 351619577)
7. Buller B, Liu X, Wang X, et al: MicroRNA-21 protects neurons from ischemic death. FEBS J 277: 4299-4307, 2010.
8. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF and Srivastava D: miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208: 549-560, 2011.
9. Siegel C, Li J, Liu F, Benashski SE and McCullough LD: miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 108: 11662-11667, 2011.
10. Yin KJ, Deng Z, Huang H, et al: miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis 38: 17-26, 2010.
11. Shi L, Chen J, Yang J, Pan T, Zhang S and Wang Z: MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352: 255-264, 2010.
12. Dong J, Zhao YP, Zhou L, Zhang TP and Chen G: Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Arch Med Res 42: 8-14, 2011.
13. McDonald JS, Milosevic D, Reddi HV, Greb SK and Algeciras-Schimnich A: Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840, 2011.
14. Devaux Y, Vausort M, Goretti E, et al: Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58: 559-567, 2012.
15. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
16. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
17. Yao R, Ma Y, Du Y, et al: The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell Mol Immunol 8: 486-495, 2011.
18. Kroh EM, Parkin RK, Mitchell PS and Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301, 2010.
19. Fichtlscherer S, Zeiher AM and Dimmeler S: Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31: 2383-2390, 2011.
20. Lorenzen JM and Thum T: Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol 7: 1528-1533, 2012.
21. Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437, 2011.
22. Doyle KP, Simon RP and Stenzel-Poore MP: Mechanisms of ischemic brain damage. Neuropharmacology 55: 310-318, 2008.
23. Xie Y, Tobin LA, Camps J, et al: MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene 32: 2442-2451, 2012.
24. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033, 2008.
25. Papagiannakopoulos T, Shapiro A and Kosik KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172, 2008.